Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.

Gaughan EM, Kim M, Mendez I, Rao AD, Wei M, So A, Zhong X, Berking C, Jiang R, Kim TM, Dalle S, Robert C, Danson S, Alam S, Charles J, Davies T, Debus D, Dzienis M, Frazer R, Gebhardt C, Geidel G, Hassel JC, Hansen I, Heppt MV, Hildebrandt L, Isaacs JM, Suh KJ, Keam B, Kim YJ, Lesimple T, Saiag P, Delibes A, Barnett R, Krepler C, Gandhi K, Qizilbash N, Shui IM, Tan XL, Sullivan RJ

Open source

DOI: 10.1136/jitc-2025-014564
Published: 2026 Mar 5
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-014564,
  title = {Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.},
  author = {Gaughan EM and Kim M and Mendez I and Rao AD and Wei M and So A and Zhong X and Berking C and Jiang R and Kim TM and Dalle S and Robert C and Danson S and Alam S and Charles J and Davies T and Debus D and Dzienis M and Frazer R and Gebhardt C and Geidel G and Hassel JC and Hansen I and Heppt MV and Hildebrandt L and Isaacs JM and Suh KJ and Keam B and Kim YJ and Lesimple T and Saiag P and Delibes A and Barnett R and Krepler C and Gandhi K and Qizilbash N and Shui IM and Tan XL and Sullivan RJ},
  year = {2026},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1136/jitc-2025-014564},
  url = {https://doi.org/10.1136/jitc-2025-014564}
}

RIS

TY  - JOUR
TI  - Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.
AU  - Gaughan EM
AU  - Kim M
AU  - Mendez I
AU  - Rao AD
AU  - Wei M
AU  - So A
AU  - Zhong X
AU  - Berking C
AU  - Jiang R
AU  - Kim TM
AU  - Dalle S
AU  - Robert C
AU  - Danson S
AU  - Alam S
AU  - Charles J
AU  - Davies T
AU  - Debus D
AU  - Dzienis M
AU  - Frazer R
AU  - Gebhardt C
AU  - Geidel G
AU  - Hassel JC
AU  - Hansen I
AU  - Heppt MV
AU  - Hildebrandt L
AU  - Isaacs JM
AU  - Suh KJ
AU  - Keam B
AU  - Kim YJ
AU  - Lesimple T
AU  - Saiag P
AU  - Delibes A
AU  - Barnett R
AU  - Krepler C
AU  - Gandhi K
AU  - Qizilbash N
AU  - Shui IM
AU  - Tan XL
AU  - Sullivan RJ
PY  - 2026
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2025-014564
UR  - https://doi.org/10.1136/jitc-2025-014564
ER  -

APA

EM, G., M, K., I, M., AD, R., M, W., A, S., X, Z., C, B., R, J., TM, K., S, D., C, R., S, D., S, A., J, C., T, D., D, D., M, D., R, F., C, G., G, G., JC, H., I, H., MV, H., L, H., JM, I., KJ, S., B, K., YJ, K., T, L., P, S., A, D., R, B., C, K., K, G., N, Q., IM, S., XL, T., & RJ, S. (2026). Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study.. Journal for immunotherapy of cancer. https://doi.org/10.1136/jitc-2025-014564

Source records

pubmed · retrieved 2026-09-26T18:44:30.115Z